Seizure other imaging findings

Jump to navigation Jump to search

Seizure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Seizure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electroencephalogram

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Seizure other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Seizure other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Seizure other imaging findings

CDC on Seizure other imaging findings

Seizure other imaging findings in the news

Blogs on Seizure other imaging findings

Directions to Hospitals Treating Seizure

Risk calculators and risk factors for Seizure other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]

Overview

3-T MRI may be helpful in patients with epilepsy and negative 1.5-T MRI.

Other Imaging Findings

3-T MRI may be helpful in patients with epilepsy and negative 1.5-T MRI.[1][2]

References

  1. Ladino LD, Balaguera P, Rascovsky S, Delgado J, Llano J, Hernández-Ronquillo L; et al. (2016). "Clinical Benefit of 3 Tesla Magnetic Resonance Imaging Rescanning in Patients With Focal Epilepsy and Negative 1.5 Tesla Magnetic Resonance Imaging". Rev Invest Clin. 68 (3): 112–8. PMID 27408997.
  2. Knake S, Triantafyllou C, Wald LL, Wiggins G, Kirk GP, Larsson PG; et al. (2005). "3T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study". Neurology. 65 (7): 1026–31. doi:10.1212/01.wnl.0000179355.04481.3c. PMID 16217054.